ClinicalTrials.gg
Not yet recruitingNCT07433101GriefDiffUpdated Feb 25, 2026

Understanding and Responding to Grief-Related Needs: A Differentiated Community Approach

An interventional study of IGLiteracy and Arm 2 - Individual Self-Help Program (ISelfHP) in Prolonged Grief Disorder (PGD), sponsored by ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida. Not yet recruiting at 1 site in Portugal. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
246
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The GriefDiff study is a randomized controlled trial evaluating a differentiated, community-based model of grief support for older adults. It compares three intervention levels-Information and Grief Literacy (IGLiteracy), Individual Self-Help Program (ISelfHP), and Moderated Self-Help Groups (MSHGroups)-to assess their effectiveness in reducing prolonged grief and psychological distress. Participants are screened for risk of Prolonged Grief Disorder and relational needs, then randomized to matched or non-matched interventions. Outcomes are measured at baseline, post-intervention (3 months), and follow-up (6 months), focusing primarily on prolonged grief symptoms and secondarily on depression, anxiety, stress, attachment, social support, and traumatic stress. The study aims to provide evidence for a cost-effective, scalable, and preventive public health model of bereavement care.

Read the detailed description

Introduction Grief in later life is a common yet under-recognized public health issue. Although most older adults adapt to bereavement without formal intervention, a significant minority develop Prolonged Grief Disorder (PGD), characterized by persistent yearning, emotional pain, and functional impairment. Older adults are particularly vulnerable due to cumulative losses, declining health, social isolation, and reduced access to psychosocial resources. Despite the documented psychological, physical, and social consequences of adverse grief reactions, prevention and early intervention remain marginal in health and social care systems.

Current responses to grief are often reactive and clinically oriented, focusing primarily on individuals who already present severe symptoms. This approach overlooks a large group of bereaved individuals experiencing substantial distress that does not yet meet diagnostic thresholds and limits opportunities for prevention. Furthermore, most existing interventions are hospital-based and individual-focused, while community-based and scalable approaches remain underdeveloped.

In line with international policy frameworks, including the World Health Organization's stepped-care model for mental health, differentiated models of grief support propose that interventions should be matched to individuals' levels of need. Such models are typically organized as a pyramid, ranging from low-intensity informational support to more structured and specialized interventions. This approach aims to optimize resource allocation, increase accessibility, and promote equity in mental health care.

Aims The primary objective of the GriefDiff study is to implement and evaluate the effectiveness of a differentiated, tiered model of grief intervention in reducing prolonged grief symptoms and psychological distress among older bereaved adults. Specifically, the study compares three intervention levels-IGLiteracy, ISelfHP, and MSHGroups-in terms of their impact on grief outcomes.

A secondary objective is to test the added value of matching interventions to participants' risk levels and relational needs, examining whether matched allocations lead to superior outcomes compared to non-matched conditions. The study also aims to identify predictors of engagement and response to intervention, including attachment patterns, social support, and traumatic stress. Ultimately, this research seeks to inform public health strategies by providing evidence for a cost-effective, community-centred, and preventive model of bereavement care.

Procedures Participants will be recruited through community and health organizations, including a national grief association and partner institutions. Individuals referred by these entities will undergo a screening process assessing eligibility, risk of PGD, and relational needs. Eligible participants will receive detailed information about the study and will provide written informed consent prior to participation.

Data collection will follow strict ethical and confidentiality standards. All data will be anonymized and securely stored. Participants will be informed of their right to withdraw at any time without consequences.

To promote retention and minimize attrition, several strategies will be implemented, including flexible scheduling, regular contact with the research team, reminders for assessment points, and the availability of both digital and non-digital intervention formats. A feedback mechanism will be established to allow participants to share their experiences and concerns throughout the study.

All interventions will be delivered within a community-based framework and will be supported by standardized manuals and materials. Intervention providers will receive specific training and ongoing supervision to ensure fidelity and consistency across conditions.

Trial Design The GriefDiff study is a rater-blinded, randomized controlled trial with three parallel intervention arms. Following baseline assessment, participants will be stratified according to risk of prolonged grief and relational needs and then randomized to one of the three intervention conditions: IGLiteracy, ISelfHP, or MSHGroups.

Randomization will be conducted using block randomization within predefined risk-by-needs strata to ensure balanced allocation across conditions. Allocation concealment will be maintained through the use of a computer-generated random sequence, managed by an independent member of the research team.

Outcome assessors will be blinded to participants' allocation. Participants will be assessed at baseline (T0), post-intervention at three months (T1), and follow-up at six months (T2). In addition to evaluating overall intervention effects, the design allows for the examination of matching effects by comparing outcomes between participants who were allocated to matched versus non-matched intervention conditions. This trial provides a rigorous methodological framework to test a differentiated, community-based model of grief care, with the potential to inform future service organization and policy in bereavement support.

02

Conditions studied

  • Prolonged Grief Disorder (PGD)

Keywords

  • Prolonged grief disorder
  • Bereavement
  • Older adults
  • Tiered intervention
  • Community-based care
  • Self-help
  • Randomized controlled trial
03

In context

Prolonged Grief Disorder

40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.

This study's planned enrollment of 246 is above the median of 73 across 36 interventional studies indexed under Prolonged Grief Disorder.

Browse Prolonged Grief Disorder studies →

Lead sponsor

ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida is the lead sponsor of 11 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Portuguese adults aged 60 years or older
  • Bereaved 1 to 12 months prior to recruitment

Exclusion criteria

Exclusion Criteria:

  • Recent serious mental illness
  • Significant cognitive impairment at screening
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
246 participants (estimated)

Study arms

  • Other
    Arm 1: Information and Grief Literacy (IGLiteracy)

    Assigned Intervention: Information and Grief Literacy Participants allocated to this arm will receive a low-intensity informational intervention aimed at enhancing grief literacy and normalizing the bereavement experience. IGLiteracy consists of a single group session (delivered online or in person) focused on psychoeducation about common and uncommon grief reactions, the grieving process, and available resources for support. Following the session, participants will receive bi-weekly brief reminders (via SMS or equivalent) over a three-month period, reinforcing key concepts and providing practical information and self-care suggestions. This arm represents the minimum active intervention and serves as a universal, low-intensity support condition.

    Behavioral: IGLiteracy

  • Other
    Arm 2: Individual Self-Help Program (ISelfHP)

    Assigned Intervention: Individual Self-Help Program Participants allocated to this arm will receive a structured, low-intensity psychological self-help intervention delivered through a digital WebApp designed for older adults. The ISelfHP aims to promote emotional regulation, psychological well-being, and adaptive grief processing. The intervention includes three main components: 1. psychoeducation about grief and emotional processes; 2. emotional regulation and well-being promotion; 3. grief elaboration and acceptance-based exercises. Participants are encouraged to complete at least one activity per week over a three-month period, although no fixed sequence or minimum dosage is imposed, allowing flexibility according to individual needs and preferences. Engagement is supported through automated reminders and brief motivational contacts by phone from the research team. Participants with low digital literacy - a non-digital alternative (printed materials with equivalent content)

    Behavioral: Arm 2 - Individual Self-Help Program (ISelfHP)

  • Other
    Arm 3: Moderated Self-Help Groups (MSHGroups)

    Assigned Intervention: Moderated Self-Help Groups Participants allocated to this arm will take part in a manualized group-based intervention facilitated by a trained psychologist. MSHGroups are semi-structured peer support groups aimed at fostering shared understanding, emotional expression, and social connection in grief. The intervention consists of weekly group sessions over a three-month period. Each session addresses key themes related to the grief process, including emotional regulation, acceptance, guilt, meaning-making, and coping strategies. Sessions are designed to last approximately three hours and follow a standardized protocol to ensure consistency across groups. The final session focuses on relapse prevention and the promotion of ongoing adaptive coping. Attendance and participant feedback will be systematically recorded. Group facilitators will receive specific training and ongoing supervision to ensure fidelity to the intervention model.

    Other: Arm 3 - Moderated Self-Help Groups (MSHGroups)

Interventions

  • BehavioralIGLiteracy

    A low-intensity intervention with one group psychoeducation session on grief reactions and available support, followed by bi-weekly SMS reminders for three months. It represents the minimum active support.

  • BehavioralArm 2 - Individual Self-Help Program (ISelfHP)

    A digital self-help program promoting emotional regulation and adaptive grief processing through psychoeducation and exercises. Participants complete activities over three months, supported by reminders and brief phone contacts. Printed materials are available if needed.

  • OtherArm 3 - Moderated Self-Help Groups (MSHGroups)

    Weekly psychologist-led peer groups for three months, focusing on emotional expression, acceptance, meaning-making, and coping, using a standardized protocol.

06

What researchers measure

Primary outcomes

  1. Prolonged Grief Scale - Revised (PG13-R)

    The PG-13-R is a 13-item self-report measure assessing Prolonged Grief Disorder symptoms according to DSM-5-TR criteria. Items are rated on a 5-point Likert scale (1 = not at all to 5 = several times a day/overwhelmingly).Total scores are calculated as the sum of all items. Total score range: 13-65. Higher scores indicate greater severity of prolonged grief symptoms. Diagnostic criteria include symptom duration (≥12 months) and functional impairment.

    Time frame: Baseline (T0), Post-intervention at 3 months (T1), and Follow-up at 6 months (T2).

Secondary outcomes

  1. Depression, Anxiety and Stress Scales - Short Form (DASS-21)

    The DASS-21 is a 21-item self-report questionnaire assessing depression, anxiety, and stress symptoms over the previous week. Each item is rated on a 4-point Likert scale (0 = did not apply to me at all; 3 = applied to me very much or most of the time). The measure consists of three subscales (Depression, Anxiety, and Stress), each comprising 7 items rated on a 4-point scale (0 to 3). Subscale scores are calculated as the sum of the 7 corresponding items. Score range (per subscale): 0 to 21. Higher scores indicate greater symptom severity in the respective domain.

    Time frame: Baseline (T0), Post-intervention at 3 months (T1), and Follow-up at 6 months (T2)

Other outcomes

  1. Sociodemographic and death-related questionnaire

    A sociodemographic and death-related questionnaire will assess: (a) social and demographic characteristics; (b) death-related characteristics (e.g., type of death, relationship with the deceased, previous care status); and (c) post-death impacts (e.g., living status, relationship-status change). Engagement and completion of the intervention tasks will also be quantitatively assessed.

    Time frame: [Screening]

  2. The Prolonged Grief Screening Tool (PGST)

    Prolonged Grief Screening Tool (PGST), a 5-item self-report screening instrument developed to identify bereaved adults at elevated risk of developing Prolonged Grief Disorder. Items assess loss-related anger and guilt, perceived closeness to the deceased, concurrent stressfu. Items are rated on a 5-point scale (1 to 5). Total score is calculated as the sum of all items. Score range: 5 to 25. Higher scores indicate greater risk of prolonged grief.

    Time frame: At screening (prior to randomization)

  3. Grief Relational Needs Scale (GRNS)

    Grief Relational Needs Scale (GRNS) is a 11 item self-report, assessing perceived relational support needs in grief across different components (e.g., security, validation, appreciation). The GRNS comprises two subscales: Need for Protection and Validation (9 items) and Need for Mutuality (3 items). Items are rated on a 5-point Likert scale (1 = "nothing" to 5 = "extremely"). Score range: 11 to 55. Higher scores indicate greater unmet relational needs.

    Time frame: At screening (prior to randomization).

  4. Adult attachment

    Experiences in Close Relationships - Relationship Structures Questionnaire (ECR-RS), adapted to assess attachment to the deceased. Items are rated on a seven-point Likert scale that ranges from 1 (strongly disagree) to 7 (strongly agree). Its 9 items are grouped into 2 dimensions: attachment-related anxiety (items 1-6) and avoidance (items 7-9). Scores for each dimension (attachment anxiety and attachment avoidance) are calculated as the mean of the corresponding items. Higher scores indicate higher attachment avoidance or anxiety. Score range (mean per dimension): 1 to 7.

    Time frame: Baseline (T0), Post-intervention at 3 months (T1), and Follow-up at 6 months (T2).

  5. Social Support

    Multidimensional Scale of Perceived Social Support (MSPSS). The MSPSS is a 12-item self-report measure assessing perceived support from family, friends, and significant others. Items are rated on a 7-point Likert scale (1 to 7). Total score is calculated as the sum of all items. Score range (total): 12 to 84. Higher scores indicate greater perceived social support.

    Time frame: Baseline (T0), Post-intervention at 3 months (T1), and Follow-up at 6 months (T2).

  6. Traumatic stress symptoms

    Impact of Event Scale - 6 item version (IES-6). The IES-6 assesses distress related to a specific stressful life event. Items are rated on a 5-point scale (0 to 4). Total score is calculated as the sum of all items. Score range (total): 0 to 24. Higher scores indicate greater traumatic stress symptom severity.

    Time frame: Baseline (T0), Post-intervention at 3 months (T1), and Follow-up at 6 months (T2)

07

Study locations

1 site
08

References and documents

Publications

  • Neto DD, Coelho A, Barbosa M, Albuquerque S. Responding to grief-related needs in older adults: protocol for a community-based matched-care trial (GriefDiff). BMC Psychol. 2026 Apr 7;14(1):761. doi: 10.1186/s40359-026-04491-9. PubMed 41947269 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Dec 2027, 21 months later.

Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 21 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Feb 25, 2026
StartEst.
Mar 1, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07433101
Lead sponsor
ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Feb 25, 2026

Study contacts

David Neto, PhD
Contact
dneto@ispa.pt
+351933220520
David Neto, PhD
Contact
dneto@ispa.pt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion